Losartan administration for 5 weeks reduced blood pressure by 10% and decreased coronary artery wall thickness by 25% in young spontaneously hypertensive rats.
Does losartan improve blood pressure, heart weight, and coronary artery structure in young spontaneously hypertensive rats?
Losartan administration from the prehypertensive period reduces blood pressure and myocardial mass, and prevents pathological structural changes in the coronary arteries of spontaneously hypertensive rats.
Effect estimate: 10% decrease
p-value: p=<0.01
Alterations in geometry and structure of coronary arteries have marked consequences on blood flow to the respective area. We evaluated long-term effect of losartan on blood pressure (BP), heart weight/body weight (HW/BW), geometry and structure of septal branch of coronary artery (RS) of young SHR and Wistar rats. Four-week-old Wistar rats and SHR were used. Losartan was administered (20 mg/kg/day) in drinking water by gavage for 5 weeks. BP was measured by plethysmographic method. Cardiovascular system was perfused with a fixative (120 mm Hg). RS was processed for electron microscopy. Wall thickness of intima + media (WT), inner diameter (ID), cross-sectional area of intima + media (CSA), volume densities (VD) of endothelial cells (EC), extracellular matrix (ECM) of intima, smooth muscle cells (SMC) and ECM of media were evaluated. BP of 4-week-old SHR did not differ from that of Wistar rats. BP, HW/BW, WT, CSA, WT/ID, CSAs of SMC, ECM of media were increased in 9-week-old SHR, whereas their VD and CSA of EC were decreased. Losartan administration decreased BP and HW/BW in both groups. Geometry of RS was affected only in SHR (reduction of WT, CSA, WT/ID and increased of ID, circumferential tension, VD and CSA of EC). Losartan administration reduced BP and myocardial mass in both groups and beneficially affected geometry and structure of coronary artery in SHR.
Koprdová et al. (Thu,) conducted a other in Hypertension (n=40). Losartan vs. Untreated control was evaluated on Blood pressure at 9 weeks of age in spontaneously hypertensive rats (10% decrease, p=<0.01). Losartan administration for 5 weeks reduced blood pressure by 10% and decreased coronary artery wall thickness by 25% in young spontaneously hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: